Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Gritstone Bio Inc (GRTS)

5.17   0.02 (0.39%) 01-26 00:48
Open: 5.0017 Pre. Close: 5.15
High: 5.25 Low: 4.89
Volume: 1,570,825 Market Cap: 351M
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.259 - 5.284 5.284 - 5.307
Low: 4.83 - 4.859 4.859 - 4.884
Close: 5.122 - 5.17 5.17 - 5.213

Technical analysis

as of: 2022-01-25 4:24:27 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 12.45     One year: 16.84
Support: Support1: 4.59    Support2: 3.82
Resistance: Resistance1: 10.66    Resistance2: 14.42
Pivot: 6.09
Moving Average: MA(5): 5.21     MA(20): 7.75
MA(100): 10.45     MA(250): 10.30
MACD: MACD(12,26): -1.68     Signal(9): -1.52
Stochastic oscillator: %K(14,3): 5.21     %D(3): 2.88
RSI: RSI(14): 25.73
52-week: High: 22.04  Low: 4.59  Change(%): -71.4
Average Vol(K): 3-Month: 2038  10-Days: 1926

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GRTS has closed above bottom band by 17.2%. Bollinger Bands are 31.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 25 Jan 2022
Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -

Thu, 13 Jan 2022
Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualized ... - The Bakersfield Californian

Wed, 12 Jan 2022
Which Vaccine Stocks Will Make You a Fortune in 2022? - Motley Fool

Wed, 05 Jan 2022
GRTS stock Bullish Premarket on COVID-19 Vaccine Data - Stocks Telegraph

Tue, 04 Jan 2022
Mid-day market update: Nasdaq dips 250 points, TherapeuticsMD shares surge - FXStreet

Tue, 04 Jan 2022
Healthcare Stocks Making Moves Tuesday: HOTH, NLSP, PSTV, ARAV, GRTS, AVRO, BLFE, ICAD - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 68
Shares Float (M) 45
% Held by Insiders 3.38
% Held by Institutions 63.81
Shares Short (K) 3,870
Shares Short P. Month (K) 1,850

Stock Financials

EPS -1.070
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.240
Profit Margin -155.87
Operating Margin -156.07
Return on Assets (ttm) -23.0
Return on Equity (ttm) -51.8
Qtrly Rev. Growth 178.4
Gross Profit (p.s.) -1.244
Sales Per Share 0.684
EBITDA (p.s.) -0.972
Qtrly Earnings Growth
Operating Cash Flow (M) -52
Levered Free Cash Flow (M) -37

Stock Valuations

PE Ratio -4.83
PEG Ratio
Price to Book value 1.60
Price to Sales 7.56
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.